TNDM Stock Analysis: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$14.07
-0.27 (-1.88%)
▼
5d:
-16.05%
30d:
-10.72%
90d:
-43.92%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 4.8/10
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TNDM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: TNDM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $14.07, which is considered oversold relative to its 30-day fair value range of $14.36 to $18.04. From a valuation perspective, the stock is trading at a discount (Forward PE: 200.3) compared to its historical average (295.4). Remarkably, the market is currently pricing in an annual earnings decline of 12.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $14.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TNDM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $29.58 (+106.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $14.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TNDM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $29.58 (+106.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.36 -
$18.04
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 106.3% below Wall St target ($29.58)
- CAUTION: 5-day price weakness (-16.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$14.36 -
$18.04
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$14.43
Resistance Level
$20.18
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
200.28
Wall Street Target
$29.58
(+106.3%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
-37.0%
Profit Margin
-9.2%
Valuation Discount vs History
-12.2% cheaper
PE vs Historical
200.3 vs 295.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.2%
(market-implied from PE analysis)
1-Year Target
$12.91
(-10%)
2-Year Target
$11.62
(-19%)
3-Year Target
$10.45
(-27%)
3-Yr Target (if PE normalizes)
(PE: 200→295)
$15.42
(+8%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 200.3 to 295.4
Stabilization Target:
$21.15
(+47.5%)
PE Expansion Potential:
+47.5%
Share & Embed Analysis
Last updated: June 23, 2026 10:15 AM ET
Data refreshes hourly during market hours. Next update: 11:15 AM
Data refreshes hourly during market hours. Next update: 11:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark David Novara
SELL
187 shares
2026-03-17
Mark David Novara
SELL
2 shares
2026-03-05
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
